Cargando…

Protection from infection with influenza A H7N9 virus in a mouse model by equine neutralizing F(ab′)(2)

Influenza A H7N9 virus has demonstrated considerable pandemic potential in China ever since early spring 2013. Until now, there have been no specific medicines to treat influenza A H7N9 virus infected patients. Development of a safe and effective H7N9 therapeutic preparation is urgently needed. To t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Zhongpeng, Fan, Chuanbo, Duan, Yueqiang, Zhang, Liangyan, Li, Min, Yang, Xiaolan, Li, Ruisheng, Yang, Penghui, Wang, Xiliang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V. 2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7106124/ https://www.ncbi.nlm.nih.gov/pubmed/25192652 http://dx.doi.org/10.1016/j.intimp.2014.08.019

Ejemplares similares

Immunization with a Live Attenuated H7N9 Influenza Vaccine Protects Mice against Lethal Challenge
por: Yang, Xiaolan, et al.
Publicado: (2015)

Response of Mice and Ferrets to a Monovalent Influenza A (H7N9) Split Vaccine
por: Duan, Yueqiang, et al.
Publicado: (2014)

Angiotensin-converting enzyme 2 (ACE2) mediates influenza H7N9 virus-induced acute lung injury
por: Yang, Penghui, et al.
Publicado: (2014)

C-C Motif Chemokine Ligand 2 (CCL2) Mediates Acute Lung Injury Induced by Lethal Influenza H7N9 Virus
por: Lai, Chengcai, et al.
Publicado: (2017)

Multiple-Clade H5N1 Influenza Split Vaccine Elicits Broad Cross Protection against Lethal Influenza Virus Challenge in Mice by Intranasal Vaccination
por: Yang, Penghui, et al.
Publicado: (2012)

Equine Immunoglobulin and Equine Neutralizing F(ab′)(2) Protect Mice from West Nile Virus Infection
por: Cui, Jiannan, et al.
Publicado: (2016)

Angiotensin-converting enzyme 2 inhibits lung injury induced by respiratory syncytial virus
por: Gu, Hongjing, et al.
Publicado: (2016)

Inhibition of infection caused by severe acute respiratory syndrome-associated coronavirus by equine neutralizing antibody in aged mice()
por: Zhou, Lili, et al.
Publicado: (2007)

Equine immunoglobulin fragment F(ab’)(2) displays high neutralizing capability against multiple SARS-CoV-2 variants
por: Gupta, Divya, et al.
Publicado: (2022)

Passive immunotherapy for influenza A H5N1 virus infection with equine hyperimmune globulin F(ab')(2 )in mice
por: Lu, Jiahai, et al.
Publicado: (2006)

Equine immunoglobulin F(ab')(2) fragments protect cats against feline calicivirus infection
por: Cui, Zhanding, et al.
Publicado: (2019)

A Functional Role of Fibroblast Growth Factor Receptor 1 (FGFR1) in the Suppression of Influenza A Virus Replication
por: Liu, Xin, et al.
Publicado: (2015)

Prophylactic Efficacy of Equine Immunoglobulin F(ab′)(2) Fragments Against Feline Parvovirus
por: Liu, Jinfeng, et al.
Publicado: (2021)

Polyclonal F(ab’)(2) fragments of equine antibodies raised against the spike protein neutralize SARS-CoV-2 variants with high potency
por: Cunha, Luis Eduardo R., et al.
Publicado: (2021)

Evaluation of the safety, immunogenicity and pharmacokinetics of equine anti-SARS–CoV F(ab′)(2) in macaque()
por: Xu, Yunsheng, et al.
Publicado: (2007)

PEGylation Prolongs the Half-Life of Equine Anti-SARS-CoV-2 Specific F(ab’)(2)
por: Xu, Mengyuan, et al.
Publicado: (2023)

Characterization of the 2009 Pandemic A/Beijing/501/2009 H1N1 Influenza Strain in Human Airway Epithelial Cells and Ferrets
por: Yang, Penghui, et al.
Publicado: (2012)

Preparation and development of equine hyperimmune globulin F(ab′)(2) against severe acute respiratory syndrome coronavirus
por: LU, Jai‐hai, et al.
Publicado: (2005)

Neutralization antibody response to booster/priming immunization with new equine influenza vaccine in Japan
por: YAMANAKA, Takashi, et al.
Publicado: (2017)

Anti-SARS-CoV-2 equine F (Ab′)(2) immunoglobulin as a possible therapy for COVID-19
por: Botosso, Viviane Fongaro, et al.
Publicado: (2022)

Refinement and Neutralization Evaluation of the F(ab’)(2) Type of Antivenom against the Deadly Jellyfish Nemopilema nomurai Toxins
por: Li, Rongfeng, et al.
Publicado: (2021)

Equine influenza – surveillance and control
por: Cullinane, Ann, et al.
Publicado: (2010)

Equine Influenza Virus and Vaccines
por: Oladunni, Fatai S., et al.
Publicado: (2021)

Monoclonal antibody against CXCL-10/IP-10 ameliorates influenza A (H1N1) virus induced acute lung injury
por: Wang, Wei, et al.
Publicado: (2013)

An omicron-based vaccine booster elicits potent neutralizing antibodies against emerging SARS-CoV-2 variants in adults
por: Li, Tao, et al.
Publicado: (2023)

COVID-19: a new challenge for human beings
por: Yang, Penghui, et al.
Publicado: (2020)

Generation of neutralizing and non-neutralizing monoclonal antibodies against H7N9 influenza virus
por: Yang, Fan, et al.
Publicado: (2020)

An Overview of Equine Influenza in South America
por: Olguin-Perglione, Cecilia, et al.
Publicado: (2021)

miR-194 Inhibits Innate Antiviral Immunity by Targeting FGF2 in Influenza H1N1 Virus Infection
por: Wang, Keyu, et al.
Publicado: (2017)

Concurrent vaccination against equine influenza and equine herpesvirus – a practical approach
por: Gildea, Sarah, et al.
Publicado: (2016)

Isolation and characterization of equine influenza virus (H3N8) from an equine influenza outbreak in Malaysia in 2015
por: Toh, Xinyu, et al.
Publicado: (2019)

Human-like antibodies neutralizing Western equine encephalitis virus
por: Hülseweh, Birgit, et al.
Publicado: (2014)

New Hosts for Equine Herpesvirus 9
por: Schrenzel, Mark D., et al.
Publicado: (2008)

Transmission of Equine Influenza Virus to English Foxhounds
por: Daly, Janet M., et al.
Publicado: (2008)

The use of equine influenza pseudotypes for serological screening
por: Scott, Simon, et al.
Publicado: (2012)

Immunoglobulin fragment F(ab’)(2) against RBD potently neutralizes SARS-CoV-2 in vitro
por: Pan, Xiaoyan, et al.
Publicado: (2020)

A Review on Equine Influenza from a Human Influenza Perspective
por: Whitlock, Fleur, et al.
Publicado: (2022)

Evaluation of concurrent vaccinations with recombinant canarypox equine influenza virus and inactivated equine herpesvirus vaccines
por: Lee, Dong-Ha, et al.
Publicado: (2022)

Rabies Post-Exposure Prophylaxis in the Philippines: Health Status of Patients Having Received Purified Equine F(ab')(2) Fragment Rabies Immunoglobulin (Favirab)
por: Quiambao, Beatriz P., et al.
Publicado: (2008)

Non-clinical safety assessment and in vivo biodistribution of CoviFab, an RBD-specific F(ab′)2 fragment derived from equine polyclonal antibodies
por: Salinas, Facundo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gdj95trivr7t2qrvh32hnjimhj